North America Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • North America
  • 350 Pages
  • No of Tables: 52
  • No of Figures: 25

North America Immunoassay Reagents And Devices Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2028
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 6.68 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • F. Hoffmann-La Roche Ltd
  • Siemens
  • Randox Laboratories Ltd
  • Abbott
  • Bio-Rad Laboratories

North America Immunoassay Reagents and Devices Market, By Product (Reagents & kits, Analyzers), Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassay, Radioimmunoassays and Others), Technique (Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR and Other Techniques), Specimen Type (Blood, Urine, Saliva and Others), Application (Infectious Diseases, Oncology And Endocrinology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening and Other Applications), End User (Hospitals, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Blood Banks, Research & Academic Laboratories and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.

North America Immunoassay Reagents and Devices Market

Market Analysis and Insights: North America Immunoassay Reagents and Devices Market

The immunoassay reagents and devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.7% in the forecast period of 2021 to 2028 and is expected to reach USD 10,178.81 million by 2028. Rising prevalence of diseases, which need technologically advanced products for diagnosis to avoid misinterpretation, is expected to fuel the growth of the immunoassay reagents and devices market in the forecast period.

Immunoassays are the tests that are performed to detect specified molecules in laboratories. It basically depends upon the antibody's integral ability to attach to the particular structure of the molecule (antigen) that is present in the sample. Antibodies are produced within the body in response to presence of antigen in the body.

Emergence in COVID-19 pandemic has led to the manufacturing of rapid diagnostic tests (RDTs) which uses immunoassay techniques are expected to act as a driver for the growth of immunoassay reagents and devices market. Product recalling has a negative impact as manufacturers invest a significant amount of money in order to replace or repair defective products which in turn, results in a decline in revenue generation. So it could be a major restraint to the immunoassay reagents and devices market in the forecast period. Increase in research and development in the immunoassay reagents and devices in order to provide enhanced or new products in the market is expected to create a window of opportunity for the growth of immunoassay reagents and devices market in the forecast period. Presence of liquid chromatography-mass spectrometry technology as an alternative method to immunoassay for detecting of biomolecules is expected to act as a challenge for the growth of the immunoassay reagents and devices market.

The immunoassay reagents and devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the immunoassay reagents and devices market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

https://www.databridgemarketresearch.com/reports/north-america-immunoassay-reagents-and-devices-market

Immunoassay Reagents and Devices Market Scope and Market Size

The immunoassay reagents and devices market is segmented based on the product, platform, technique, specimen type, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2021, reagents & kits segment is dominating due to its higher usage in drug development as well as in disease detection.
  • On the basis of platform, the immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others. In 2021, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing tests, accurate result and many others.
  • On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques. In 2021, enzyme-linked immunosorbent assays segment is dominating because it is highly sensitive, simple to perform, offer accurate result for any disease detection or in any drug development.
  • On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others. In 2021, blood segment is dominating the market because antigen can be easily detected from the blood.
  • On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening and other applications. In 2021, oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays.
  • On the basis of end user, the immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories and others. In 2021, pharmaceutical and biotechnology companies segment is dominating the market because of high usage of immunoassays for the drug development.

North America Immunoassay Reagents and Devices Market Country Level Analysis

North America immunoassay reagents and devices market is analyzed and market size information is provided by the country, product, platform, technique, specimen type, application and end user as referenced above.

The countries covered in the North America immunoassay reagents and devices market report are the U.S., Canada and Mexico.

The platform segment in the U.S. is dominating the North America immunoassay reagents and devices market owing to increasing preference of many biotechnology and pharma industries for the detection and drug development. While, Canada is dominating due to increased research and development to provide enhanced products.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to enhance the Awareness for Immunoassay Reagents and Devices is boosting the Immunoassay Reagents and Devices Market

The immunoassay reagents and devices market also provides you with detailed immunoassay reagents and devices market analysis for every country growth in immunoassay reagents and devices market. Additionally, it provides the detailed information regarding the immunoassay reagents and devices market players’ strategy and their geographical presence. The data is available for historic period 2011 to 2019.

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

The immunoassay reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America immunoassay reagents and devices market.

The major companies dealing in the North America immunoassay reagents and devices market report are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A, Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract, agreement and launches are also initiated by the companies’ worldwide which are also accelerating the immunoassay reagents and devices market.

For instance,

  • In July 2020, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Preliminary performance of the assay has been established and the kit is now undergoing clinical evaluation in several hospitals to further confirm clinical performance. Initial data collected on more than 700 samples has demonstrated specificity above 99 percent.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company footprints in the immunoassay reagents and devices market which also provides the benefit for organization’s profit growth.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 INDUSTRY INSIGHTS

5.1 NEW PRODUCT LAUNCHES:

5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES IN NORTH AMERICA

6.1.2 EMERGENCE OF COVID-19 PANDEMIC IN NORTH AMERICA

6.1.3 WIDE APPLICATION OF IMMUNOASSAY IN NORTH AMERICA

6.1.4 INCREASING HEALTHCARE EXPENDITURE IN NORTH AMERICA

6.1.5 WIDE USE IN DRUG SCREENING TESTS IN NORTH AMERICA

6.2 RESTRAINTS

6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA

6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA

6.3 OPPORTUNITIES

6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES

6.3.2 STRATEGIC INITATIVES BY THE COMPANIES

6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY

6.4 CHALLENGES

6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES

6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY

7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 REAGENTS & KITS

7.2.1 ELISA REAGENTS & KITS

7.2.1.1 THIRD-GENERATION ELISA

7.2.1.2 FIFTH-GENERATION ELISA

7.2.1.3 FOURTH-GENERATION ELISA

7.2.1.4 FIRST-GENERATION ELISA

7.2.1.5 SECOND-GENERATION ELISA

7.2.2 ELISPOT REAGENTS & KITS

7.2.3 RAPID TEST REAGENTS & KITS

7.2.4 WESTERN BLOT REAGENTS & KITS

7.2.5 OTHER REAGENTS & KITS

7.3 ANALYZERS

7.3.1 BY TYPE

7.3.1.1 OPEN-ENDED SYSTEMS

7.3.1.2 CLOSED-ENDED SYSTEMS

7.3.2 BY DEVICE TYPE

7.3.2.1 BENCH-TOP

7.3.2.2 FLOOR STANDING

8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

8.1 OVERVIEW

8.2 ENZYME IMMUNOASSAY

8.3 FLUORESCENCE IMMUNOASSAYS

8.4 CHEMILUMINESCENCE IMMUNOASSAYS

8.5 RADIOIMMUNOASSAYS

8.6 OTHERS

9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE

9.1 OVERVIEW

9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS

9.3 ENZYME-LINKED IMMUNOSPOT

9.4 RAPID TESTS

9.5 WESTERN BLOTTING

9.6 IMMUNO-PCR

9.7 OTHER TECHNIQUES

10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

10.1 OVERVIEW

10.2 BLOOD

10.3 URINE

10.4 SALIVA

10.5 OTHERS

11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 ONCOLOGY AND ENDOCRINOLOGY

11.3 HEMATOLOGY & BLOOD SCREENING

11.4 CARDIOLOGY

11.5 INFECTIOUS DISEASES

11.6 BONE & MINERAL DISORDERS

11.7 AUTOIMMUNE DISORDERS

11.8 TOXICOLOGY

11.9 NEONATAL SCREENING

11.1 OTHER APPLICATIONS

12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

12.1 OVERVIEW

12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

12.3 CLINICAL LABORATORIES

12.4 HOSPITALS

12.5 RESEARCH & ACADEMIC LABORATORIES

12.6 BLOOD BANKS

12.7 OTHERS

13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION

13.1 NORTH AMERICA MARKET

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 COMPANY PROFILE

15.1 F. HOFFMANN-LA ROCHE LTD

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 ABBOTT

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 2.3 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 DIASORIN S.P.A

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 PERKINELMER INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 BIOMÉRIEUX SA

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 AGILENT TECHNOLOGIES, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 BD

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENTS

15.9 BIOCHECK, INC.

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BIO-TECHNE

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENTS

15.11 BIO-RAD LABORATORIES, INC.

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENTS

15.12 LUMINEX CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENTS

15.13 MERCK KGAA

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENTS

15.14 MESO SCALE DIAGNOSTICS, LLC

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENTS

15.15 ORTHO CLINICAL DIAGNOSTICS

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 QIAGEN

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 QUIDEL CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENTS

15.18 RANDOX LABORATORIES LTD.

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

15.19 SIEMENS

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENTS

15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENTS

15.21 SYSMEX CORPORATION

15.21.1 COMPANY SNAPSHOT

15.21.2 REVENUE ANALYSIS

15.21.3 PRODUCT PORTFOLIO

15.21.4 RECENT DEVELOPMENTS

15.22 THERMO FISHER SCIENTIFIC INC.

15.22.1 COMPANY SNAPSHOT

15.22.2 REVENUE ANALYSIS

15.22.3 PRODUCT PORTFOLIO

15.22.4 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.

TABLE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 23 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 24 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 25 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)

TABLE 26 U.S. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 27 U.S. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 28 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 29 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 30 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)

TABLE 31 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 32 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 33 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 34 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 35 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)

TABLE 36 CANADA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 37 CANADA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 39 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 40 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)

TABLE 41 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 42 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 43 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 44 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 45 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)

TABLE 46 MEXICO REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 MEXICO ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 49 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 50 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)

TABLE 51 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 52 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS

FIGURE 4 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NOTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION

FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET

FIGURE 14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020

FIGURE 15 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020

FIGURE 16 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020

FIGURE 17 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020

FIGURE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020

FIGURE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020

FIGURE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)

FIGURE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)

FIGURE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 23 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 24 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)

FIGURE 25 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America Immunoassay Reagents and Devices Market size will be worth USD 10,178.81 million by 2028.
The North America Immunoassay Reagents and Devices Market growth rate will be 4.7% by 2028.
The Emergence in COVID-19 pandemic has led to the manufacturing of rapid diagnostic tests (RDTs) which uses immunoassay techniques are the growth drivers of the North America Immunoassay Reagents and Devices Market.
The product, platform, technique, specimen type, application and end user are the factors on which the North America Immunoassay Reagents and Devices Market.
The major companies in the North America Immunoassay Reagents and Devices Market are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A, Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC